Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.380
+0.280 (6.83%)
At close: Jun 26, 2026, 4:00 PM EDT
4.300
-0.080 (-1.83%)
After-hours: Jun 26, 2026, 4:34 PM EDT
Prelude Therapeutics Employees
Prelude Therapeutics had 79 employees as of December 31, 2025. The number of employees decreased by 52 or -39.69% compared to the previous year.
Employees
79
Change (1Y)
-52
Growth (1Y)
-39.69%
Revenue / Employee
$211,646
Profits / Employee
-$984,785
Market Cap
434.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Artiva Biotherapeutics | 106 |
| Editas Medicine | 87 |
| Century Therapeutics | 78 |
| Cybin | 50 |
| Eupraxia Pharmaceuticals | 49 |
PRLD News
- 17 days ago - Prelude Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 18 days ago - Prelude Therapeutics Transcript: AGM 2026 - Transcripts
- 24 days ago - Prelude Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Prelude Therapeutics initiated with Early-Stage Biotech at Goldman Sachs - TheFly
- 6 weeks ago - Prelude Therapeutics reports Q1 EPS (13c), consensus (27c) - TheFly
- 6 weeks ago - Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Prelude Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Prelude Therapeutics Quarterly report: Q1 2026 - Filings